or Try an Advanced Search...

    Technical Analysis for ENTX - Entera Bio Ltd.

    Grade Last Price % Change Price Change
    F 1.62 4.52% 0.07
    ENTX closed down 4.91 percent on Wednesday, November 20, 2024, on 68 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical ENTX trend table...
    Date Alert Name Type % Chg
    Gapped Up Strength 4.52%
    Below Lower BB Weakness 4.52%
    Down 3 Days in a Row Weakness 4.52%
    Down 4 Days in a Row Weakness 4.52%
    Lower Bollinger Band Touch Weakness 4.52%
    Oversold Stochastic Weakness 4.52%
    Stochastic Reached Oversold Weakness -0.61%
    Down 3 Days in a Row Weakness -0.61%
    Oversold Stochastic Weakness -0.61%
    Gapped Down Weakness -2.41%
    Older End-of-Day Signals for ENTX ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Lower Bollinger Band about 2 hours ago
    Up 3% about 2 hours ago
    Fell Below Previous Day's Low about 2 hours ago
    Up 2% about 2 hours ago
    Up 1% about 2 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    ENTX Chart by TradingView
    Basic chart:

    Profile

    Entera Bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule therapeutics for use in orphan indications and other areas with significant unmet medical need. The Company is initially applying its technology to develop an oral formulation of parathyroid hormone (PTH) for hypoparathyroidism (EB612) and osteoporosis (EB613).
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Endocrine System Hormones Thyroid Osteoporosis Molecule Therapeutics Glands Hypoparathyroidism Parathyroid Hormone

    Is ENTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 8 Entera Bio GAAP EPS of -$0.08 misses by $0.03, revenue of $0.04M in-line
    Nov 8 Entera Bio Ltd. (ENTX) Reports Q3 Loss, Tops Revenue Estimates
    Nov 8 Entera Bio Reports Q3 2024 Financial Results and Provides Business Updates
    Oct 4 Are Medical Stocks Lagging Argenx (ARGX) This Year?
    Sep 26 ENTX & OPK Stock May Gain Following Positive PK/PD Research Data
    Sep 25 Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic Disorders
    Sep 18 Is Entera Bio (ENTX) Stock Outpacing Its Medical Peers This Year?
    Aug 30 We're Keeping An Eye On Entera Bio's (NASDAQ:ENTX) Cash Burn Rate
    Aug 20 Entera Bio to Participate in Upcoming Investor and Scientific Conferences
    Aug 15 All You Need to Know About Entera Bio (ENTX) Rating Upgrade to Buy
    See more ENTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.35
    52 Week Low 0.52
    Average Volume 71,183
    200-Day Moving Average 1.81
    50-Day Moving Average 1.84
    20-Day Moving Average 1.75
    10-Day Moving Average 1.69
    Average True Range 0.10
    RSI (14) 31.03
    ADX 21.26
    +DI 8.43
    -DI 24.06
    Chandelier Exit (Long, 3 ATRs) 1.64
    Chandelier Exit (Short, 3 ATRs) 1.86
    Upper Bollinger Bands 1.93
    Lower Bollinger Band 1.58
    Percent B (%b) -0.08
    BandWidth 19.99
    MACD Line -0.05
    MACD Signal Line -0.04
    MACD Histogram -0.017
    Fundamentals Value
    Market Cap 54.99 Million
    Num Shares 35.5 Million
    EPS -0.34
    Price-to-Earnings (P/E) Ratio -4.56
    Price-to-Sales 2280.62
    Price-to-Book 5.12
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.76
    Resistance 3 (R3) 1.78 1.74 1.73
    Resistance 2 (R2) 1.74 1.68 1.73 1.71
    Resistance 1 (R1) 1.64 1.65 1.62 1.62 1.70
    Pivot Point 1.60 1.60 1.59 1.59 1.60
    Support 1 (S1) 1.50 1.54 1.48 1.48 1.40
    Support 2 (S2) 1.46 1.51 1.45 1.39
    Support 3 (S3) 1.36 1.46 1.38
    Support 4 (S4) 1.34